Results 121 to 130 of about 13,620 (172)

Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies. [PDF]

ACS Bio Med Chem Au
Cavada BS, Osterne VJS, Oliveira MV, Ferreira WP, Neto CC, Nascimento KS, Pinto-Junior VR.   +6 more
europepmc   +1 more source

Determination of Hemagglutinin and Neuraminidase Genetic Variation of Human Influenza A(H1N1)pdm09 Virus Strain Isolated From Deceased Patients in Shiraz, Iran: A Cross-Sectional Study. [PDF]

Health Sci Rep
Barkhori R, Edalat F, Pirbonyeh N, Goudarzi Y, Hosseini SY, Moattari A.   +5 more
europepmc   +1 more source

Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift. [PDF]

Nat Commun
de Paiva Froes Rocha R, Tomris I, Bowman CA, Stevens E, Kantorow J, Plitt CM, Peng W, Oeverdieck S, Galdino Andrade T, Ferguson JA, Jung DD, Marques RE, Herfst S, Snijder J, Chakraborty S, Torrents de la Peña A, Berndsen ZT, de Vries RP, Ward AB.   +18 more
europepmc   +1 more source

Pre-existing cross-reactive immunity to highly pathogenic avian influenza 2.3.4.4b A(H5N1) virus in the United States. [PDF]

Nat Commun
Li ZN, Liu F, Jung YJ, Jefferson S, Holiday C, Gross FL, Tzeng WP, Carney P, Kates A, York IA, Safdar N, Zhou J, Medina MJ, Cioce V, Oshansky CM, Todd Davis C, Stevens J, Tumpey T, Levine MZ.   +18 more
europepmc   +1 more source

Development of an H9N2 vaccine strain with enhanced neuraminidase immunogenicity via dual hemagglutinin and neuraminidase modification. [PDF]

J Vet Sci
Song JH, Son SE, Kim H, Kim SJ, An SH, Lee CY, Choi KS, Kwon HJ.   +7 more
europepmc   +1 more source

Intra-patient neuraminidase mutations in avian H5N1 influenza virus reduce sialidase activity to complement weaker hemagglutinin binding and facilitate human infection. [PDF]

PLoS Pathog
Watanabe Y, Ibrahim MS, Arai Y, Kuroda D, Elgendy EM, Nakakita SI, Takeda Y, Nghia Bui V, Ono T, Ushiba S, Daidoji T, Sriwilaijaroen N, Ogawa H, Matsumoto K, Suzuki Y, Nakaya T.   +15 more
europepmc   +1 more source

Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera. [PDF]

Microbiol Immunol
Sato K, Shimasaki N, Fujisaki S, Nishijima H, Kuwahara T, Nakai Y, Murano K, Asanuma H, Watanabe S, Harada Y, Ryo A, Tashiro M, Itamura S.   +12 more
europepmc   +1 more source

Cholera toxin B subunit fusion enhances the immunogenicity of the H5 stem domain against the H5N2 avian influenza virus. [PDF]

Clin Exp Vaccine Res
Lee C, Kim S, You J, Seo M, Kim Y, Park J, Park HW, Rho J.   +7 more
europepmc   +1 more source

Monoclonal antibodies against influenza viruses: a clinical trials review. [PDF]

Front Immunol
Mota KG, Moro AM.
europepmc   +1 more source

Heterologous sequential immunization using chimeric mRNA and protein vaccines with HA-stem and S-RBD enhanced protective mucosal immunity against influenza and COVID-19. [PDF]

Sci Rep
Li Y, Wang X, Zeng X, Zhu B.
europepmc   +1 more source